[go: up one dir, main page]

MX344529B - Derivados antibioticos de 2 - oxo -oxazolidin - 3, 5 -diilo. - Google Patents

Derivados antibioticos de 2 - oxo -oxazolidin - 3, 5 -diilo.

Info

Publication number
MX344529B
MX344529B MX2014005637A MX2014005637A MX344529B MX 344529 B MX344529 B MX 344529B MX 2014005637 A MX2014005637 A MX 2014005637A MX 2014005637 A MX2014005637 A MX 2014005637A MX 344529 B MX344529 B MX 344529B
Authority
MX
Mexico
Prior art keywords
oxazolidin
diyl
oxo
antibiotic derivatives
alkyl
Prior art date
Application number
MX2014005637A
Other languages
English (en)
Other versions
MX2014005637A (es
Inventor
Hubschwerlen Christian
Surivet Jean-Philippe
Rueedi Georg
Zumbrunn Acklin Cornelia
Original Assignee
Actelion Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actelion Pharmaceuticals Ltd filed Critical Actelion Pharmaceuticals Ltd
Publication of MX2014005637A publication Critical patent/MX2014005637A/es
Publication of MX344529B publication Critical patent/MX344529B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
    • C07D513/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Detergent Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

La invención se refiere a compuestos antibacterianos de la Fórmula 1; (ver Fórmulas) en donde R1a representa H o carboxi y R1b representa H, o R1a y R1b representan juntos el grupo *-C(O)-NH-S-# o el grupo *-C(OH)=N-S-# en donde "*" representa el punto de unión de R1a y "#" representa el punto de unión de R1b; R2 representa H, alquilo de 1 a 3 átomos de carbono, hidroxialquilo de 1 a 3 átomos de carbono, bencilo o cicloalquilo de 3 a 5 átomos de carbono; R3 representa H o halógeno; U representa N o CR4; en donde R4 es H o alcoxi de 1 a 3 átomos de carbono; A representa CH, B representa NH y m representa 1 o 2 y n representa 1 o 2; o A representa N, B está ausente, m representa 2 y n representa 2; Y representa CH o N; y Q representa O o S; y sales de tales compuestos.
MX2014005637A 2011-11-08 2012-11-07 Derivados antibioticos de 2 - oxo -oxazolidin - 3, 5 -diilo. MX344529B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IB2011054968 2011-11-08
PCT/IB2012/056236 WO2013068948A1 (en) 2011-11-08 2012-11-07 2-oxo-oxazolidin-3,5-diyl antibiotic derivatives

Publications (2)

Publication Number Publication Date
MX2014005637A MX2014005637A (es) 2014-06-23
MX344529B true MX344529B (es) 2016-12-19

Family

ID=47258051

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014005637A MX344529B (es) 2011-11-08 2012-11-07 Derivados antibioticos de 2 - oxo -oxazolidin - 3, 5 -diilo.

Country Status (21)

Country Link
US (1) US9079922B2 (es)
EP (1) EP2776431B1 (es)
JP (1) JP6030146B2 (es)
KR (1) KR20140096337A (es)
AR (1) AR088691A1 (es)
AU (1) AU2012335207B2 (es)
BR (1) BR112014011064A8 (es)
CA (1) CA2854264A1 (es)
CL (1) CL2014001154A1 (es)
ES (1) ES2581056T3 (es)
HK (1) HK1202288A1 (es)
IL (1) IL232463A0 (es)
IN (1) IN2014CN04126A (es)
MX (1) MX344529B (es)
PH (1) PH12014500831A1 (es)
PL (1) PL2776431T3 (es)
RU (1) RU2616609C2 (es)
SG (1) SG11201401710PA (es)
TW (1) TWI594996B (es)
WO (1) WO2013068948A1 (es)
ZA (1) ZA201404176B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI415853B (zh) 2008-10-07 2013-11-21 Actelion Pharmaceuticals Ltd 三環唑啶酮抗生素化合物
BR112015026261A8 (pt) 2013-04-16 2017-12-26 Actelion Pharmaceuticals Ltd Derivados biaromáticos antibacterianos
AR096135A1 (es) 2013-05-02 2015-12-09 Actelion Pharmaceuticals Ltd Derivados de la quinolona
AR102256A1 (es) 2014-10-15 2017-02-15 Actelion Pharmaceuticals Ltd Derivados biaromáticos básicos antibacterianos con sustitución de aminoalcoxi
MA41168A (fr) 2014-12-17 2017-10-24 Acraf Nouveaux composés antibactériens
MA41169A (fr) * 2014-12-17 2017-10-24 Acraf Composés antibactériens à large spectre d'activité
SG11201806166WA (en) * 2016-02-08 2018-08-30 Redx Pharma Plc Heterocyclic compounds, in particular 2-oxo-4,4,5,5,6,6,7,7-octahydrobenzoxazole derivatives, and their use as antibacterial compounds
WO2017137743A1 (en) * 2016-02-08 2017-08-17 Redx Pharma Plc Antibacterial compounds
GB201602235D0 (en) * 2016-02-08 2016-03-23 Redx Pharma Plc Antibacterial compounds
SMT202000335T1 (it) 2016-06-08 2020-07-08 Acraf Nuovi composti antibatterici
TW201833120A (zh) 2017-02-17 2018-09-16 瑞士商愛杜西亞製藥有限公司 芳基噁唑啶酮抗生素化合物
US10912780B2 (en) 2017-06-08 2021-02-09 Bugworks Research, Inc. Heterocyclic compounds useful as anti-bacterial agents and method for production thereof
EP3717490B1 (en) 2017-11-29 2023-05-24 Bugworks Research, Inc. Anti-bacterial heterocyclic compounds and their synthesis

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3149104A (en) 1961-01-03 1964-09-15 Sterling Drug Inc 4-hydroxy-7-styryl-1, 8-naphthyridine-3-carboxylic acids and esters
HU168497B (es) 1972-12-18 1976-05-28
SE444566B (sv) 1977-09-20 1986-04-21 Bellon Labor Sa Roger 7-dialkylamin-6-halogen-4-oxo-1,4-dihydrokinolin-3-karboxylsyra, forfarande for framstellning derav och farmaceutiskt preparat derav
GB1598915A (en) 1977-09-20 1981-09-23 Bellon Labor Sa Roger 1,4-dihydro-quinoline-3-carboxylic acid derivatives process for their preparation and composition containing them
CS274601B2 (en) 1983-07-27 1991-09-15 Dainippon Pharmaceutical Co Method of 1,8-naphthyridine derivative production
JPS62205060A (ja) 1986-03-04 1987-09-09 Kyorin Pharmaceut Co Ltd ８位置換キノロンカルボン酸誘導体
FI871419A (fi) 1986-03-31 1987-10-01 Sankyo Co Kinolin-3-karboxylsyraderivat, deras framstaellning och anvaendning.
JP2631854B2 (ja) 1987-12-23 1997-07-16 藤本製薬株式会社 新規な１，８−ナフチリジン誘導体
DE4301246A1 (de) 1993-01-19 1994-07-21 Bayer Ag Chinolon- und Naphthyridoncarbonsäurederivate
EP1553093A1 (en) 2002-06-28 2005-07-13 Kaneka Corporation Process for preparation of optically active 1-substituted amino-2,3-epoxypropanes, intermediates for the synthesis thereof and process for preparation of the intermediates
BRPI0409955A (pt) * 2003-04-30 2006-04-25 Morphochem Ag Komb Chemie uso de antibióticos hìbridos de oxazolidinona - quinolina para o tratamento de antrax e outras infecções
ATE401326T1 (de) * 2003-12-18 2008-08-15 Morphochem Ag Komb Chemie Oxazolidinon-chinolon hybrid antibiotika
CA2572442A1 (fr) * 2004-07-30 2006-03-09 Palumed S.A. Molecules hybrides qa ou q est une aminoquinoleine et a est un residu antibiotique, leur synthese et leurs utilisations en tant qu'agent antibacterien
CA2578081A1 (en) 2004-09-01 2006-03-09 Ubitrak Inc. System for gaming chip identification and counting
US20090156577A1 (en) 2004-09-09 2009-06-18 Benjamin Davis 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
JP2009532504A (ja) 2006-04-06 2009-09-10 グラクソ グループ リミテッド 抗菌薬
KR101118402B1 (ko) * 2006-11-10 2012-03-07 액테리온 파마슈티칼 리미티드 5-하이드록시메틸-옥사졸리딘-2-원 유도체
CL2008001002A1 (es) 2007-04-11 2008-10-17 Actelion Pharmaceuticals Ltd Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana.
CL2008001003A1 (es) * 2007-04-11 2008-10-17 Actelion Pharmaceuticals Ltd Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana.
JP5323088B2 (ja) * 2007-12-18 2013-10-23 アクテリオン ファーマシューティカルズ リミテッド ５−アミノシクリルメチル−オキサゾリジン−２−オン誘導体
MX2010008921A (es) * 2008-02-22 2010-09-07 Actelion Pharmaceuticals Ltd Derivados de oxazolidinona.
TWI415853B (zh) 2008-10-07 2013-11-21 Actelion Pharmaceuticals Ltd 三環唑啶酮抗生素化合物
US20110195949A1 (en) * 2008-10-10 2011-08-11 Actelion Pharmaceuticals Ltd. 2-benzothiophenyl- and 2-naphthyl-oxazolidinones and their azaisostere analogues as antibacterial agents
JP5490809B2 (ja) * 2008-10-10 2014-05-14 アクテリオン ファーマシューティカルズ リミテッド オキサゾリジニル抗生物質
TW201121965A (en) 2009-09-28 2011-07-01 Lg Life Sciences Ltd Use of a quinolone derivative containing 7-(4-aminomethyl-3-oxime)pyrrolidine group that is capable of inducing granulocyte colony stimulating factor for treatment of neutropenia and recovery of hematopoiesis
CN101792443A (zh) 2010-03-09 2010-08-04 北京欧凯纳斯科技有限公司 氟代喹诺酮衍生物及其制备方法和用途

Also Published As

Publication number Publication date
RU2014123109A (ru) 2015-12-20
EP2776431B1 (en) 2016-05-04
SG11201401710PA (en) 2014-09-26
AU2012335207B2 (en) 2017-05-25
EP2776431A1 (en) 2014-09-17
BR112014011064A8 (pt) 2017-12-26
CN103917539A (zh) 2014-07-09
JP6030146B2 (ja) 2016-11-24
MX2014005637A (es) 2014-06-23
ZA201404176B (en) 2016-05-25
PH12014500831A1 (en) 2019-08-07
IN2014CN04126A (es) 2015-07-10
CA2854264A1 (en) 2013-05-16
IL232463A0 (en) 2014-06-30
KR20140096337A (ko) 2014-08-05
TW201326166A (zh) 2013-07-01
AU2012335207A1 (en) 2014-07-03
US20150051188A1 (en) 2015-02-19
AR088691A1 (es) 2014-06-25
HK1202288A1 (en) 2015-09-25
PL2776431T3 (pl) 2016-11-30
CL2014001154A1 (es) 2014-09-12
WO2013068948A1 (en) 2013-05-16
JP2014532754A (ja) 2014-12-08
RU2616609C2 (ru) 2017-04-18
TWI594996B (zh) 2017-08-11
US9079922B2 (en) 2015-07-14
BR112014011064A2 (pt) 2017-06-13
ES2581056T3 (es) 2016-08-31

Similar Documents

Publication Publication Date Title
PH12014500831A1 (en) 2-oxo-oxazolidin-3,5-diyl antibiotic derivatives
RS54260B1 (en) AMINODIHYDROTIAZINE DERIVATIVES AS BACE INHIBITORS FOR ALZHEIMER DISEASE TREATMENT
HRP20080113T3 (en) Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
MY158520A (en) Tricyclic oxazolidinone antibiotic compounds
TW201129556A (en) Novel antiplatelet agent
WO2008108380A3 (en) Pyrrole compounds
MX337516B (es) Derivados de 1,2,4-tiazolidin-3-ona y uso en el tratamiento del cancer.
MA32956B1 (fr) Derives de 5-amino-2-(1-hydroxyethyl)-tetrahydropyrane
MX2009005449A (es) Compuesto heteromonociclico y uso del mismo.
TW200833686A (en) Fused bicyclic derivatives of 2,4-diaminopyrimidine as ALK and c-Met inhibitors
TNSN08407A1 (en) Organic compounds
MX2015008971A (es) Derivados de pirimidina pirido- o pirrolo-fusionados como inhibidores de autotaxina para tratar dolor.
CY1111671T1 (el) Ετεροκυκλικη ενωση
ECSP099091A (es) Profarmaco de compuesto de cinamida
TW200602322A (en) Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs
MY160882A (en) Biocidal composition and method
MX2009011769A (es) Derivados de piridona como inhibidores de mapk p38a.
CY1118623T1 (el) Ενωσεις τετραϋδροπυρρολοθειαζινων ως αναστολεις της bace
PH12019500839A1 (en) Therapeutic compounds and methods of use thereof
JO3143B1 (ar) مركبات تتراهيدرو بيرولو ثيازين
MY139612A (en) Benzoxazine derivatives as 5-th6 modulators and uses thereof
TW200508215A (en) Cyclic tertiary amine compounds
MY136824A (en) Substituted benzoxazinones and uses thereof
DE60014143D1 (de) Antimikrobielle 4-oxochinolizine mit 2-pyridongerüsten als teilstruktur
TW200728291A (en) Amide derivatives

Legal Events

Date Code Title Description
FG Grant or registration